BioXcel Therapeutics (BTAI) to Offer 2M Shares of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. CHRW
3. MRVL
4. RXO
5. OPCH
6. NVDA
7. APLD
8. SPY
9. AMD
10. HUBS

Go back to BioXcel Therapeutics (BTAI) to Offer 2M Shares of Common Stock

BioXcel Therapeutics Announces Proposed Public Offering of Common Stock

February 19, 2020 4:54 PM EST

NEW HAVEN, Conn., Feb. 19, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTI or the Company) (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced that it has commenced an underwritten public offering of 2,000,000 shares of its common stock. In connection with the offering, BTI intends to grant the underwriters a 30-day option to purchase up to an additional 300,000 shares of common stock from BTI.  To the extent the underwriters exercise their option to purchase additional shares of common stock, the Company intends to use the net proceeds from the sale of additional shares to... More